Esomeprazole Magnesium
Rank #210 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$66.3M
Total Cost
964,193
Total Claims
$66.3M
Total Cost
34,500
Prescribers
$69
Cost per Claim
110,606
Beneficiaries
1,957,276
30-Day Fills
$1,921
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$66.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $66.3M total
Top Prescribers of Esomeprazole Magnesium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Xiangsheng Zheng | Internal Medicine | Birmingham, AL | 996 | $168K |
| 2 | Xiaoqin Yin | Family Practice | Flushing, NY | 940 | $113K |
| 3 | Victor Fariwa | Internal Medicine | Brooklyn, NY | 127 | $102K |
| 4 | Bo Chen | Internal Medicine | New York, NY | 187 | $82K |
| 5 | John Lu | Family Practice | Richmond, TX | 331 | $70K |
| 6 | Singmay Siu | Internal Medicine | Brooklyn, NY | 748 | $70K |
| 7 | Horacio Hau | Family Practice | Corpus Christi, TX | 260 | $70K |
| 8 | Dina Liberman | Internal Medicine | Brooklyn, NY | 201 | $69K |
| 9 | Christina Abraham | Physician Assistant | Sunrise, FL | 2,004 | $61K |
| 10 | Xiandong Shi | Internal Medicine | Flushing, NY | 650 | $58K |
| 11 | Mohamad Khansa | Internal Medicine | Dearborn, MI | 380 | $54K |
| 12 | Amanda English | Nurse Practitioner | Anson, TX | 217 | $53K |
| 13 | Moromoke Odina | Internal Medicine | Fort Drum, NY | 272 | $52K |
| 14 | Lilia Wexley | Family Practice | Los Angeles, CA | 150 | $48K |
| 15 | Krista Hamilton | Nurse Practitioner | Abilene, TX | 151 | $47K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 207 | Tenofovir Alafenamide (Vemlidy) | $68.7M | 44,509 |
| 208 | Abaloparatide (Tymlos) | $68.4M | 24,417 |
| 209 | Treprostinil Diolamine (Orenitram Er) | $68.2M | 5,964 |
| 210 | Esomeprazole Magnesium (Esomeprazole Magnesium) | $66.3M | 964,193 |
| 211 | Dabigatran Etexilate Mesylate (Dabigatran Etexilate) | $66.0M | 220,652 |
| 212 | Netarsudil Mesylate (Rhopressa) | $65.6M | 129,116 |
| 213 | Risperidone Microspheres (Risperdal Consta) | $64.8M | 47,567 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology